Publication | Closed Access

Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1,2,4]triazolo[4,3-a]quinoxaline analogues targeting DHFR and E. coli DNA gyrase B

Antimicrobial ScreeningAntimicrobial Drug DiscoveryPharmacokinetic ProfilingMedicineAntibacterial AgentAntimicrobial ChemotherapyMicrobiologyAntimicrobial CompoundDrug DevelopmentPharmacologyAntimicrobial ResistanceDrug Discovery